HK1045686A1 - Benzisoxazoles and phenones as alpha2-antagonists. - Google Patents

Benzisoxazoles and phenones as alpha2-antagonists.

Info

Publication number
HK1045686A1
HK1045686A1 HK02105098A HK02105098A HK1045686A1 HK 1045686 A1 HK1045686 A1 HK 1045686A1 HK 02105098 A HK02105098 A HK 02105098A HK 02105098 A HK02105098 A HK 02105098A HK 1045686 A1 HK1045686 A1 HK 1045686A1
Authority
HK
Hong Kong
Prior art keywords
benzisoxazoles
phenones
alpha2
antagonists
Prior art date
Application number
HK02105098A
Other versions
HK1045686B (en
Inventor
Ludo Edmond Josephine Kennis
Josephus Carolus Mertens
Serge Maria Aloysius Pieters
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of HK1045686A1 publication Critical patent/HK1045686A1/en
Publication of HK1045686B publication Critical patent/HK1045686B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Psychology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
HK02105098.8A 1998-12-21 2002-07-09 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS HK1045686B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204358 1998-12-21
PCT/EP1999/010054 WO2000037466A1 (en) 1998-12-21 1999-12-14 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS

Publications (2)

Publication Number Publication Date
HK1045686A1 true HK1045686A1 (en) 2002-12-06
HK1045686B HK1045686B (en) 2005-04-01

Family

ID=8234508

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105098.8A HK1045686B (en) 1998-12-21 2002-07-09 BENZISOXAZOLES AND PHENONES AS α2-ANTAGONISTS

Country Status (30)

Country Link
US (1) US6576640B1 (en)
EP (1) EP1140934B1 (en)
JP (1) JP4717216B2 (en)
KR (2) KR20060093139A (en)
CN (1) CN1154646C (en)
AR (1) AR021924A1 (en)
AT (1) ATE251622T1 (en)
AU (1) AU765751B2 (en)
BG (1) BG65162B1 (en)
BR (1) BR9916427A (en)
CA (1) CA2355716C (en)
CZ (1) CZ294532B6 (en)
DE (1) DE69911995T2 (en)
EA (1) EA003606B1 (en)
EE (1) EE200100329A (en)
ES (1) ES2209553T3 (en)
HK (1) HK1045686B (en)
HR (1) HRP20010444A2 (en)
HU (1) HUP0104812A3 (en)
ID (1) ID28967A (en)
IL (2) IL143830A0 (en)
NO (1) NO317892B1 (en)
NZ (1) NZ511411A (en)
PL (1) PL196958B1 (en)
SK (1) SK285560B6 (en)
TR (1) TR200101813T2 (en)
TW (1) TWI229673B (en)
UA (1) UA71938C2 (en)
WO (1) WO2000037466A1 (en)
ZA (1) ZA200105067B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04000036A (en) 2001-07-05 2004-05-21 Upjohn Co (hetero) aryl substituted benzofurans as 5-ht ligands.
WO2003082825A1 (en) * 2002-04-03 2003-10-09 Orion Corporation Use of an alfa2-adrenoreceptor antagonist for cns-related diseases
EP1757605A4 (en) 2004-04-12 2007-12-19 Taisho Pharmaceutical Co Ltd Cyclic amine compound
AU2006275694A1 (en) * 2005-07-28 2007-02-08 Bristol-Myers Squibb Company Substituted tetrahydro-1H-pyrido(4,3,b)indoles as serotonin receptor agonists and antagonists

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3419568A (en) * 1966-12-07 1968-12-31 Abbott Lab Derivatives of 1,2,3,4-tetrahydro-5h-pyrido[4,3b]indoles
US3382250A (en) * 1966-12-07 1968-05-07 Abbott Lab Aroylalkyl derivatives of 1, 2, 3, 4-tetrahydro-5h-pyrido[4, 3b]indoles
US3718657A (en) * 1970-12-03 1973-02-27 Abbott Lab Certain-2-substituted-1,2,3,4-tetrahydro-beta or gamma carbolines
JPS4729395U (en) * 1971-04-26 1972-12-04
AR207799A1 (en) * 1974-04-01 1976-10-29 Pfizer PROCEDURE TO PREPARE AZACICLO (3,4-A) -N-PHENYLINDOLES-2-SUBSTITUTE
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
FR2570701B1 (en) 1984-09-27 1987-05-22 Synthelabo FURO (3,2-C) PYRIDINES DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
DE3522959A1 (en) * 1985-06-27 1987-01-08 Merck Patent Gmbh INDOLDER DERIVATIVES
JPH0256485A (en) 1988-04-27 1990-02-26 Glaxo Group Ltd Lactam derivative
WO1994008040A1 (en) * 1992-09-25 1994-04-14 Synaptic Pharmaceutical Corporation Dna encoding human alpha 1 adrenergic receptors and uses thereof
US5508306A (en) * 1992-11-13 1996-04-16 Synaptic Pharmaceutical Corporation Aromatic amine derivatives
US5403847A (en) 1992-11-13 1995-04-04 Synaptic Pharmaceutical Corporation Use of α1C specific compounds to treat benign prostatic hyperlasia
UA52681C2 (en) * 1997-04-08 2003-01-15 Янссен Фармацевтика Н.В. Derivatives of 1,2,3,4-tetrahydro-benzofuro [3,2,-c] pyridine

Also Published As

Publication number Publication date
UA71938C2 (en) 2005-01-17
DE69911995T2 (en) 2004-09-02
EP1140934B1 (en) 2003-10-08
KR20060093139A (en) 2006-08-23
EA003606B1 (en) 2003-06-26
EP1140934A1 (en) 2001-10-10
TWI229673B (en) 2005-03-21
ATE251622T1 (en) 2003-10-15
AU2432700A (en) 2000-07-12
EA200100709A1 (en) 2001-12-24
CZ294532B6 (en) 2005-01-12
BG105521A (en) 2001-12-29
ID28967A (en) 2001-07-19
KR20010075650A (en) 2001-08-09
SK285560B6 (en) 2007-03-01
SK8582001A3 (en) 2001-12-03
ES2209553T3 (en) 2004-06-16
HUP0104812A3 (en) 2003-12-29
DE69911995D1 (en) 2003-11-13
BR9916427A (en) 2001-09-04
AU765751B2 (en) 2003-09-25
JP4717216B2 (en) 2011-07-06
NZ511411A (en) 2002-12-20
IL143830A (en) 2007-07-24
HK1045686B (en) 2005-04-01
HUP0104812A2 (en) 2002-04-29
EE200100329A (en) 2002-08-15
CA2355716C (en) 2010-05-18
CN1154646C (en) 2004-06-23
NO20012783D0 (en) 2001-06-06
US6576640B1 (en) 2003-06-10
NO20012783L (en) 2001-06-06
WO2000037466A1 (en) 2000-06-29
ZA200105067B (en) 2002-06-20
PL196958B1 (en) 2008-02-29
IL143830A0 (en) 2002-04-21
CZ20012120A3 (en) 2001-10-17
PL348421A1 (en) 2002-05-20
KR100657540B1 (en) 2006-12-14
JP2002533341A (en) 2002-10-08
HRP20010444A2 (en) 2002-06-30
TR200101813T2 (en) 2001-12-21
CA2355716A1 (en) 2000-06-29
CN1331692A (en) 2002-01-16
BG65162B1 (en) 2007-04-30
AR021924A1 (en) 2002-09-04
NO317892B1 (en) 2004-12-27

Similar Documents

Publication Publication Date Title
ZA200005136B (en) Dihydropyrimides.
ZA200004956B (en) Vaccine composition.
HK1042653A1 (en) External preparation.
ZA995673B (en) Fungicidal trifluoromethylalkylamino-triazolopyrimidines.
ZA99254B (en) Benzosulfone derivatives.
ZA9811939B (en) Novel macrolides.
ZA200101637B (en) Cyclone.
ZA991272B (en) Novel thiobenzamides.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA993123B (en) Trisresorcinyltriazines.
HK1045686A1 (en) Benzisoxazoles and phenones as alpha2-antagonists.
ZA99832B (en) Improved security arrangements.
ZA992071B (en) Cutting system.
GB0029720D0 (en) I.S machine7544232001
ZA994441B (en) Mill.
MXPA01004506A (en) Improved reactor.
HK1028588A1 (en) Case.
GB2344342B (en) I.S Machine
ZA993536B (en) Autoclaves.
ZA994776B (en) Impeller insert.
ZA99925B (en) Composition.
ZA992062B (en) Rotary Springkler.
ZA200006160B (en) Vaccine.
ZA99872B (en) Vaccine.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20081214